Platinum Asset Management’s flagship international fund initiated positions in several pharmaceutical companies in the ...

I was at Novartis headquarters in Basel yesterday for the company’s Q4 results, and my burning question was – did the company have any designs on entering the viral vector-based gene therapy ...

Barrett only joined Novartis in January from Pfizer but said that she is unwilling to relocate to Basel where Novartis’ oncology headquarters is based, and has instead accepted a leadership role ...

Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

ZURICH (Reuters) - Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of ...

The Swiss pharma giant said the new positions would include nearly 6,500 in construction and 1,000 at new and expanded ...

Swiss pharmaceutical Roche has announced plans to invest billions in the US within the next five years, creating 12,000 new ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, becoming the latest pharmaceutical company to shift operations to the ...